金日品牌怎么样 申请店铺

我要投票 金日在保健养生行业中的票数:1072 更新时间:2026-02-11
金日,是一家有二十多年历史,集制药、医疗、保健、食品、金融、贸易、房地产为一体的多元化实业集团,拥有香港及内地十几家下属企业,并在新加坡、加拿大等地进行各类投资贸易活动,已在国内厦门、福州、顺德、深圳

外推网助力金日品牌出海!将品牌入驻外推网,定制金日品牌推广信息,可以显著提高金日产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

金日怎么样

金日,是一家有二十多年历史,集制药、医疗、保健、食品、金融、贸易、房地产为一体的多元化实业集团,拥有香港及内地十几家下属企业,并在新加坡、加拿大等地进行各类投资贸易活动,已在国内厦门、福州、顺德、深圳等地设立制造基地。

金日制药(中国)有限公司作为金日集团全资子公司,成立于1991年,是集团健康产业在国内的主要生产基地,是一家集研发、生产和销售为一体的现代化制药企业。经过数十年不懈的努力,公司产品从单一的洋参丸,发展到目前胶囊剂、片剂、口服液、冲剂、膏剂、凝胶剂、膜剂等12条生产线近百个品种,产品畅销不滞,深受广大消费者的青睐,成为福建省具规模的现代化药品及保健品生产企业。

20多年的品牌建设,已使“金日牌”系列产品享誉海内外,“金日洋参”已成为中国洋参行业品牌,公司自主研发、生产的“金日牌心源素胶囊”深受中国心脑健康患者的喜爱。

金日制药(中国)有限公司不仅拥有历史悠久的品牌、拥有雄厚的资金实力、拥有专业的管理人才、拥有完善的产业化基础、更拥有强大的新产品研发能力。仅在厦门一地就有研发技术人员56人,其中博士研究生1人,硕士5人,高级工程师7人,工程师39人。  金日制药(中国)有限公司在加大自主研发力度的基础上,与中国药科大学、上海中医药大学、北京大学、南京中医药大学、福建中医药大学、江西中医学院、东南大学、华中科技大学、同济医学院、第四军医大学西京医院等国内外多家科研机构、学府紧密合作,获得了多项自主科研技术及核心自主知识产权。

Jinri is a diversified industrial group with a history of more than 20 years, integrating pharmacy, medical treatment, health care, food, finance, trade and real estate. It has more than a dozen subordinate enterprises in Hong Kong and the mainland, and carries out various investment and trade activities in Singapore, Canada and other places. It has established manufacturing bases in Xiamen, Fuzhou, Shunde, Shenzhen and other places in China. As a wholly-owned subsidiary of kingri group, kingri Pharmaceutical (China) Co., Ltd. was founded in 1991. It is the main production base of the group's health industry in China and a modern pharmaceutical enterprise integrating research and development, production and sales. After decades of unremitting efforts, our products have developed from a single ginseng pill to nearly 100 varieties of 12 production lines, such as capsules, tablets, oral liquids, granules, ointments, gels and film agents. The products are sold well without delay, and are well received by consumers and become the modern pharmaceutical and health care products manufacturers in Fujian. More than 20 years of brand building has made "Jinri brand" series products famous at home and abroad, "jinriyangshen" has become the brand of China's foreign ginseng industry, and the "Jinri brand Xinyuansu capsule" independently developed and produced by the company is deeply loved by Chinese heart and brain health patients. Jinri Pharmaceutical (China) Co., Ltd. not only has a long history of brand, has a strong financial strength, has professional management personnel, has a sound industrial foundation, but also has a strong ability of new product research and development. In Xiamen alone, there are 56 R & D technicians, including 1 doctoral candidate, 5 masters, 7 senior engineers and 39 engineers. Jinri Pharmaceutical (China) Co., Ltd., on the basis of increasing its independent research and development efforts, cooperates closely with many scientific research institutions and institutions at home and abroad, such as China Pharmaceutical University, Shanghai University of traditional Chinese medicine, Peking University, Nanjing University of traditional Chinese medicine, Fujian University of traditional Chinese Medicine, Jiangxi University of traditional Chinese medicine, Southeast University, Huazhong University of science and technology, Tongji Medical College, Xijing Hospital of the Fourth Military Medical University, etc And obtained a number of independent scientific research technologies and core independent intellectual property rights.

本文链接: https://brand.waitui.com/db89dd4f3.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

武商集团:股东达孜银泰拟减持不超3%股份

36氪获悉,武商集团公告,持股5%以上股东达孜银泰商业发展有限公司计划在公告披露之日起十五个交易日后的三个月内(2026年3月13日-2026年6月12日),以集中竞价和/或大宗交易方式减持公司股份不超过2249.71万股(占公司剔除回购专用账户后总股本的3%);其中集中竞价不超过749.90万股(1%),大宗交易不超过1499.81万股(2%);减持原因为资金周转需要,股份来源为协议转让取得。

37分钟前

美股大型科技股盘前涨跌互现,英伟达涨近1%

36氪获悉,美股大型科技股盘前涨跌互现,截至发稿,英伟达涨近1%,特斯拉涨0.71%,微软涨0.47%,亚马逊涨0.43%,Arm涨0.31%,奈飞涨0.05%,Meta涨0.01%;苹果跌0.46%,谷歌跌0.37%。

37分钟前

热门中概股美股盘前多数上涨,爱奇艺涨超1%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,爱奇艺涨超1%,理想汽车、腾讯音乐涨近1%,阿里巴巴涨0.79%,小鹏汽车涨0.74%,京东、拼多多涨0.5%;百度跌0.02%。

37分钟前

华森制药:股东刘小英拟减持不超3%股份

36氪获悉,华森制药公告,持股5%以上股东刘小英因个人资金需求,计划自公告披露之日起至15个交易日届满次日起的3个月内(即2026年3月13日至2026年6月12日),通过集中竞价方式减持不超过417.60万股(不超过公司总股本的1%),通过大宗交易方式减持不超过835.19万股(不超过公司总股本的2%),合计减持不超过1252.79万股,即不超过公司总股本的3%。

37分钟前

日科化学:股东赵东日拟减持不超3%公司股份

36氪获悉,日科化学公告,公司持股5%以上股东赵东日计划自2026年3月12日至2026年6月11日期间,通过集中竞价交易和大宗交易方式减持公司股份不超过1349.8万股,即不超过公司总股本的3%。减持价格将根据减持时的二级市场价格确定,减持原因为个人资金需求。本次减持计划实施具有不确定性。

37分钟前

本页详细列出关于金日的品牌信息,含品牌所属公司介绍,金日所处行业的品牌地位及优势。
咨询